News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Glucon Announces New Clinical Study Results Of Aprise(TM) In A Poster Presentation At The American Diabetes Association's 66th Scientific Sessions, In Washington, D.C.


6/12/2006 1:21:54 PM

BOULDER, Colo.--(BUSINESS WIRE)--June 12, 2006--Glucon Inc., developer of innovative continual blood glucose monitoring devices, announced the complete results of its recent clinical study of Aprise at the American Diabetes Association's 66th Scientific Sessions, in Washington, D.C., June 9-13, 06 The data are also published in the Scientific Sessions Abstract Book, the June supplement to the journal Diabetes.

Read at press release


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES